Tag: DLBCL

Post ASH 2022: High-grade B-cell Lymphomas, what’s new?

Posted on by admin

Review Article

Haema 2023; 14(1-4):34-38

Pineopi Vryttia, Sotirios G. Papageorgiou

Second Department of Internal Medicine and Research Institute, Hematology Unit, Attikon University General Hospital

 

Full PDF |

Continue reading “Post ASH 2022: High-grade B-cell Lymphomas, what’s new?” →

Elevated Soluble Transferrin Receptor (sTfR) in A Patient with High Grade Diffuse Large B Cell Lymphoma: Could it Serve as a Biomarker of Monitoring the Disease? A Case Report and Review of the Literature

Posted on by admin

Case Report

Haema 2019; 10(1):50-55

Vasiliki Palaska,1 Anna Paschali,2 Theodora Triantafyllou,1 Konstantina Keramidioti,1 Evgenia Verrou,1 Nikolaos Drougos,1 Dimitra Markala,3 Polyzo Kazila,4 Persefoni Xirou,5 Asimina Papanikolaou,6 Emmanouil Panagiotidis,2 Elisavet Chadjipavlidou,2 Pavlina Konstantinidou,1 Eirini Katodritou1

1Department of Hematology, Theagenion Cancer Hospital Thessaloniki, 2Department of Nuclear Medicine, Theagenion Cancer Hospital, Thessaloniki; 3Department of Hematology Laboratory Theagenion Cancer Hospital, Thessaloniki, 4Department of Immunology, Theagenion Cancer Hospital, Thessaloniki; 5Department of Pathology, Theagenion Cancer Hospital, Thessaloniki, 6Department of Hemopathology, “Evangelismos” General Hospital, Athens, Greece

Full PDF |

Continue reading “Elevated Soluble Transferrin Receptor (sTfR) in A Patient with High Grade Diffuse Large B Cell Lymphoma: Could it Serve as a Biomarker of Monitoring the Disease? A Case Report and Review of the Literature” →